These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28111336)

  • 1. Clinical Features, Response to Treatment, and Outcomes of IgG4-Related Sclerosing Cholangitis.
    Tanaka A; Tazuma S; Okazaki K; Nakazawa T; Inui K; Chiba T; Takikawa H
    Clin Gastroenterol Hepatol; 2017 Jun; 15(6):920-926.e3. PubMed ID: 28111336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan.
    Tanaka A; Tazuma S; Nakazawa T; Isayama H; Tsuyuguchi T; Inui K; Takikawa H
    J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):217-225. PubMed ID: 28103424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan.
    Tanaka A; Tazuma S; Okazaki K; Tsubouchi H; Inui K; Takikawa H
    J Hepatobiliary Pancreat Sci; 2014 Jan; 21(1):43-50. PubMed ID: 24353071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012.
    Ohara H; Okazaki K; Tsubouchi H; Inui K; Kawa S; Kamisawa T; Tazuma S; Uchida K; Hirano K; Yoshida H; Nishino T; Ko SB; Mizuno N; Hamano H; Kanno A; Notohara K; Hasebe O; Nakazawa T; Nakanuma Y; Takikawa H; ; ; ;
    J Hepatobiliary Pancreat Sci; 2012 Sep; 19(5):536-42. PubMed ID: 22717980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case report of immunoglobulin G4-related sclerosing cholangitis with multiple relapse.
    Dong X; Huo N; Wu Z; Wang G; Wang H; Zhao H
    Medicine (Baltimore); 2018 May; 97(19):e0700. PubMed ID: 29742724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience.
    Ali AH; Bi Y; Machicado JD; Garg S; Lennon RJ; Zhang L; Takahashi N; Carey EJ; Lindor KD; Buness JG; Tabibian JH; Chari ST
    J Gastroenterol; 2020 Nov; 55(11):1087-1097. PubMed ID: 32770464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference from bile duct cancer and relationship between bile duct wall thickness and serum IgG/IgG4 levels in IgG4-related sclerosing cholangitis.
    Kuwatani M; Kawakami H; Zen Y; Kawakubo K; Kudo T; Abe Y; Kubo K; Sakamoto N
    Hepatogastroenterology; 2014 Oct; 61(135):1852-6. PubMed ID: 25713877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin G4-related cholangitis: a variant of IgG4-related systemic disease.
    Novotný I; Dítě P; Trna J; Lata J; Husová L; Geryk E
    Dig Dis; 2012; 30(2):216-9. PubMed ID: 22722442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cases of immunoglobulin G4-related sclerosing cholangitis in which transabdominal ultrasonography was useful in diagnosis and follow-up observation.
    Kobori I; Suda T; Nakamoto A; Saito H; Okawa O; Sudo R; Gyotoku Y; Katayama Y; Tamano M
    J Med Ultrason (2001); 2016 Apr; 43(2):271-7. PubMed ID: 27033871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management, outcomes and survival of an Australian IgG4-SC cohort: The MOSAIC study.
    Kemp W; Majeed A; Mitchell J; Majumdar A; Tse E; Skoien R; Croagh D; Dev A; Gao H; Weltman M; Craig P; Stuart K; Cheng W; Edmunds S; Lee E; Sood S; Metz A; Thompson A; Sinclair M; Beswick L; Nicoll A; Riordan S; Braund A; Muller K; MacQuillan G; Sandanayake N; Shackel N; Roberts SK
    Liver Int; 2021 Dec; 41(12):2934-2943. PubMed ID: 34392596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a scoring system for differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.
    Moon SH; Kim MH; Lee JK; Baek S; Woo YS; Cho DH; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol; 2017 Apr; 52(4):483-493. PubMed ID: 27470434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of clinical characteristics and treatment of immunoglobulin G4-associated cholangitis: A retrospective cohort study of 39 IAC patients.
    Xiao J; Xu P; Li B; Hong T; Liu W; He X; Zheng C; Zhao Y
    Medicine (Baltimore); 2018 Feb; 97(8):e9767. PubMed ID: 29465558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the long-term outcomes between proximal and distal IgG4-related sclerosing cholangitis: A multicenter cohort study.
    Cho SH; Song TJ; Park JS; Yoon JH; Yang MJ; Yoon SB; Lee JM; Lee YN; Kim SH; Choi EK; Park SW; Oh D; Park DH; Lee SS; Seo DW; Lee SK; Kim MH
    J Gastroenterol Hepatol; 2023 Apr; 38(4):648-655. PubMed ID: 36710432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohort.
    Naitoh I; Kamisawa T; Tanaka A; Nakazawa T; Kubota K; Takikawa H; Unno M; Masamune A; Kawa S; Nakamura S; Okazaki K;
    Dig Liver Dis; 2021 Oct; 53(10):1308-1314. PubMed ID: 33664004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
    Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of elevated serum IgG4 levels in patients with primary sclerosing cholangitis.
    Benito de Valle M; Müller T; Björnsson E; Otten M; Volkmann M; Guckelberger O; Wiedenmann B; Sadik R; Schott E; Andersson M; Berg T; Lindkvist B
    Dig Liver Dis; 2014 Oct; 46(10):903-8. PubMed ID: 25091876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis.
    Tanaka A
    Gut Liver; 2019 May; 13(3):300-307. PubMed ID: 30205418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor response of initial steroid therapy for IgG4-related sclerosing cholangitis with multiple organs affected.
    Liu W; Chen W; He X; Qu Q; Hong T; Li B
    Medicine (Baltimore); 2017 Mar; 96(12):e6400. PubMed ID: 28328835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localized intrahepatic IgG4-related sclerosing cholangitis (IgG4-SC) as an additional type of IgG4-SC: a systematic analysis of 12 cases.
    Mo Z; Ramen K; Shan Y; Zhou M; Zheng X; Wu X; Yu Z; Ji X; Zhang Q; Zeng Q
    Scand J Gastroenterol; 2018 Mar; 53(3):312-318. PubMed ID: 29313399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of steroid administration for diagnosis of IgG4-related sclerosing cholangitis.
    Kubo N; Suzuki H; Kobayashi T; Araki K; Sasaki S; Wada W; Kuwano H
    Int Surg; 2012; 97(2):145-9. PubMed ID: 23343338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.